JACQUALINE DICKSON: Open Payments
NPI 1124586995 · COLLIERVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$884 in 44 payments from 17 companies in 2025. Trend: 2023 $1,525 · 2024 $1,212 · 2025 $884
Food & beverage: $884
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $200 |
| Novo Nordisk Inc | 5 | $101 |
| Lilly USA, LLC | 5 | $94 |
| SANOFI-AVENTIS U.S. LLC | 3 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Corcept Therapeutics | 2 | $48 |
| PFIZER INC. | 2 | $40 |
| ABBVIE INC. | 2 | $34 |
Products named: AIRSUPRA, MOUNJARO, Wegovy, FARXIGA, REXULTI, TZIELD, CAPLYTA, TRINTELLIX.
Industry payments across TN — which companies pay providers there.
